- Home
- CAAP vs BHVN Comparison
CAAP vs BHVN Comparison
Compare CAAP & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- BHVN
- Stock Information
- Founded
- CAAP 1998
- BHVN 2013
- Country
- CAAP Luxembourg
- BHVN United States
- Employees
- CAAP N/A
- BHVN N/A
- Industry
- CAAP Aerospace
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CAAP Consumer Discretionary
- BHVN Health Care
- Exchange
- CAAP Nasdaq
- BHVN Nasdaq
- Market Cap
- CAAP 2.4B
- BHVN 4.8B
- IPO Year
- CAAP 2018
- BHVN 2017
- Fundamental
- Price
- CAAP $19.00
- BHVN $50.81
- Analyst Decision
- CAAP Strong Buy
- BHVN Strong Buy
- Analyst Count
- CAAP 1
- BHVN 13
- Target Price
- CAAP $21.50
- BHVN $61.92
- AVG Volume (30 Days)
- CAAP 88.3K
- BHVN 899.6K
- Earning Date
- CAAP 11-13-2024
- BHVN 11-12-2024
- Dividend Yield
- CAAP N/A
- BHVN N/A
- EPS Growth
- CAAP 114.63
- BHVN N/A
- EPS
- CAAP 2.22
- BHVN N/A
- Revenue
- CAAP $1,471,077,000.00
- BHVN N/A
- Revenue This Year
- CAAP $25.78
- BHVN N/A
- Revenue Next Year
- CAAP $18.74
- BHVN $95.28
- P/E Ratio
- CAAP $8.53
- BHVN N/A
- Revenue Growth
- CAAP N/A
- BHVN N/A
- 52 Week Low
- CAAP $10.57
- BHVN $25.97
- 52 Week High
- CAAP $19.31
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- CAAP 60.61
- BHVN 50.97
- Support Level
- CAAP $17.43
- BHVN $50.58
- Resistance Level
- CAAP $19.22
- BHVN $54.63
- Average True Range (ATR)
- CAAP 0.44
- BHVN 2.14
- MACD
- CAAP 0.01
- BHVN -0.62
- Stochastic Oscillator
- CAAP 72.24
- BHVN 7.24
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.